Freeman, MD, Joshua. “FDA Approves Alzheimer’s Drug Against the Recommendation of Its Scientific Panel. Be Very Concerned”. RRNMF Neuromuscular Journal 2, no. 5 (December 20, 2021): 5–6. Accessed April 4, 2025. https://journals.ku.edu/rrnmf/article/view/15979.